Cargando…
Global challenges of implementing human papillomavirus vaccines
Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable. Socio-economically marginalized women in emerging and developing, and many advanced economi...
Autores principales: | Graham, Janice E, Mishra, Amrita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143925/ https://www.ncbi.nlm.nih.gov/pubmed/21718495 http://dx.doi.org/10.1186/1475-9276-10-27 |
Ejemplares similares
-
Human Papillomavirus Vaccination After COVID-19
por: Toh, Zheng Quan, et al.
Publicado: (2021) -
Getting Human Papillomavirus Vaccination Back on Track: Protecting Our National Investment in Human Papillomavirus Vaccination in the COVID-19 Era
por: Gilkey, Melissa B., et al.
Publicado: (2020) -
Addressing the implementation challenge of the global biodiversity framework
por: Phang, Sui C., et al.
Publicado: (2020) -
COVID-19 Vaccination in Children: Lessons Learned From Human Papillomavirus Vaccination
por: Mansfield, Lisa N., et al.
Publicado: (2022) -
Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program
por: Ujiie, Mugen
Publicado: (2022)